Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC).

CAPHRI, The Research Institute of the University Maastricht0 个研究点目标入组 97 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

•1. Male and female patients aged 1-4,5 years with a familial predisposition for asthma in the first degree, who have experienced at least 2 separate periods with wheeze lasting at least 2 days each documented by their general practitioner;
•2. And for each patient, who enters the study a written informed consent by the parent or guardian of the patient should be obtained.

•1. Patients, who have been treated with pulmonary anti-inflammatory inhaled drugs during more than 2 weeks or anti-inflammatory oral drugs during more than 1 week preceding the study. Patients, who have been hospitalised for asthma in the 2 weeks prior to the study;
•2. Patients, who have serious respiratory morbidity (e.g. broncho-pulmonary dysplasia, cystic fibrosis, tuberculosis);

发起方

CAPHRI, The Research Institute of the University Maastricht